Notably, GZMK-expressing CD8+ T cells are positively correlated with the response to immunotherapy in clear cell renal cell carcinoma [38], esophageal cancer [37], and peripheral blood of non-small cell lung cancer patients [39]. Here, CD8A is linked to esophageal cancer.